Robert A. Floyd
Gründer bei Otologic Pharmaceutics, Inc.
Profil
Robert A.
Floyd is the founder of Otologic Pharmaceutics, Inc. He currently works as a Principal at Oklahoma Medical Research Foundation since 1974.
Previously, he worked at Purdue University from 1966 to 1969.
Dr. Floyd received his doctorate degree from Purdue University in 1969, his graduate degree from the University of California, Davis in 1969, and his undergraduate and graduate degrees from the University of Kentucky in 1965.
Aktive Positionen von Robert A. Floyd
Unternehmen | Position | Beginn |
---|---|---|
Oklahoma Medical Research Foundation
Oklahoma Medical Research Foundation Investment Trusts/Mutual FundsMiscellaneous Oklahoma Medical Research Foundation provides investment advice. The company was founded in 1946 and is headquartered in Oklahoma City, OK. | Corporate Officer/Principal | 12.03.2012 |
Otologic Pharmaceutics, Inc.
Otologic Pharmaceutics, Inc. Pharmaceuticals: MajorHealth Technology Otologic Pharmaceutics, Inc. develops treatment for acute hearing loss. Its product HPN1010 is an oral medication to treat acute hearing loss to reduce the development of permanent hearing disorders. The company was founded by Richard Kopke, Robert A. Floyd and Dave karlman and is headquartered in Oklahoma City, OK. | Gründer | - |
Ausbildung von Robert A. Floyd
University of Kentucky | Graduate Degree |
Purdue University | Doctorate Degree |
University of California, Davis | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Oklahoma Medical Research Foundation
Oklahoma Medical Research Foundation Investment Trusts/Mutual FundsMiscellaneous Oklahoma Medical Research Foundation provides investment advice. The company was founded in 1946 and is headquartered in Oklahoma City, OK. | Miscellaneous |
Otologic Pharmaceutics, Inc.
Otologic Pharmaceutics, Inc. Pharmaceuticals: MajorHealth Technology Otologic Pharmaceutics, Inc. develops treatment for acute hearing loss. Its product HPN1010 is an oral medication to treat acute hearing loss to reduce the development of permanent hearing disorders. The company was founded by Richard Kopke, Robert A. Floyd and Dave karlman and is headquartered in Oklahoma City, OK. | Health Technology |